Notes

Choosing The Right Names Of Company In Denmark
Gran Recovery & Health


A List Of Danish Biotech Companies If you're looking for reliable data on Danish biotech firms, consider using a company like BoldData. The database is compiled by the company and includes data from Central Business Register and Danish Chambers of Commerce. The accuracy of the data will assist you in creating a successful marketing campaign for your biotech firm. BoldData's data will help you to develop a more targeted marketing campaign.

Orphazyme

A late-stage biopharmaceutical company Orphazyme is currently developing a new treatment to treat the neurodegenerative disease Niemann-Pick type C. The company has a lead candidate in development , Arimoclomol. The company plans to submit an application for marketing authorization with the EMA in the second quarter of 2020.

The company has a long track record of focusing its efforts on rare diseases. Marja Jaattela and Thomas Kirkegaard founded the company in 2010. They've focused on the storage of lysosomes, and specifically.

Symphogen

French pharmaceutical company Servier has agreed to purchase Symphogen, the Danish biotech company that has developed an antibody discovery platform for cancer treatments. Servier's pipeline of antibodies will be strengthened through this acquisition. Since over two years, the two companies have been working together within the field of immuno-oncology. Servier will be able to utilize Symphogen's expertise, technology and resources.

Symphogen's management team is knowledgeable and diverse. Symphogen's CEO, Kirsten Drejer is a seasoned industry professional with a track record of establishing an extensive pipeline and helping to propel Symphogen to a solid financial position. The company also has assets that have positive clinical data.

Galecto Biotech

Galecto Biotech is a Danish biotech company that develops novel drugs to treat serious illnesses. The company's principal product inhibits galectin-3, a protein, which is involved in a variety of immune and inflammatory processes. The company is currently conducting clinical trials to treat idiopathic pulmonary and fibrosis. It has formed a partnership with Bristol-Myers Squibb and has plans to start additional clinical trials to treat fibrotic diseases.

Galecto Biotech's offerings were created using a research technology that targets galectin-3. The company's teams for product development are focused on the development and commercialization of therapeutic drugs that are chemically produced however they're not limited to this. The company is also in late-stage clinical trials for galectin modulator. This could eventually lead to treatment for asthma and nasal polyposis.

Novo Nordisk

In the United States, Dicerna Pharmaceuticals has been purchased by the biotech company. Dicerna has developed medicines that were based on RNA interference, which shuts down the genes that cause certain ailments.

The company plans to invest 17 billion Danish Kroner in three new manufacturing facilities. They will also expand the existing facility in Kalundborg, Denmark. The new facilities will boost the global value chain's capacity. They will also boost the production of oral and injectable products. The new facilities will be fitted with state-of the-art production technology.

Novozymes

Novozymes, an Danish biotechnology company, specializes in industrial enzymes. The company is a diverse company with a range of end markets and revenues are largely generated in industries like agriculture, bio-energy household care, as well as wastewater solutions. Novozymes was founded in 1988 and has its headquarters in Copenhagen in Denmark.

The Danish biotech company has a long track record of success in product roll-out. Its predecessor, Nordisk Insulinlaboratorium, launched its first enzyme, trypsin, in 1941. This enzyme was originally used to soften leather. The company also invented the process of fermentation that allows enzyme production. In the late 1980s, the company presented the world's first enzyme for the production of detergents: lipolase. This enzyme enhanced the freshness of white bread as well as buns.

Lilly

A majority of the world's notable biotech companies are based in Denmark. These companies use innovative biotechnology to fight cancer, create vaccines and other medical solutions. Oncology Venture ApS specializes in research and development in the area of cancer. AquaGreen is which is a Danish biotech engineering company and STipe Therapeutics are other notable companies. They harness the immune system's natural immunity to fight cancer. Acesion Pharma, a Danish biotech company, is also creating drugs to treat atrial fibrillation.

Denmark and Sweden have a long history in the medical technology and biotechnology industries. The countries are among the top five pharmaceutical exporters in the world. Denmark is the second-highest per-capita R&D expenditure in the European pharmaceutical industry following Switzerland. Additionally, 60 percent of the pharmaceutical activities in Scandinavia are concentrated in the Medicon Valley, a Danish-Swedish cross-border cluster.

Innovent


Innovent Biotech recently obtained exclusive rights for Eli Lilly's cancer treatments in China. This deal will allow Innovent to control the pricing marketing, sales, and distribution of the drugs. The two companies will collaborate on the development of treatments for medical issues that are major and unmet, including eczema and cancer.

Innovent has 16 potential products in its pipeline. Seven are currently in the process of clinical development. The company also collaborated with Eli Lilly to develop three Chinese cancer treatments. Ascentage is an Danish biotech company has also collaborated with Oriza Ventures, and the Chinese state-backed SDIC Fund Management.



Here's my website: https://www.cooley.digital/references/